ARMI Annual Report 2016

2016 saw yet another year of exceptional research excellence at the Australian Regenerative Medicine Institute (ARMI). The number of papers published in leading journals with an impact factor of greater than 10, more than doubled in 2016.

The year was bolstered with new opportunities to commercialise research at the Institute, with the announcement of a global hub of commercialisation at ARMI, the Centre for Commercialisation of Regenerative Medicine Australia.